F-2-O1-03
LISTENING AND COMMUNICATION TRAINING AFTER COCHKLEAR IMPLANT
Jian Shi, Minqi Huang (Zhujiang Hospital, Guangzhou, China)
Abstract: To improve the listening and communication abilities, two adult cochlear postimplant patients got regular listening and communication training. They went to hospital once a week for eight weeks for a one hour listening training session and communication. Between sessions they needed to practice listening and communication training at home for at least one hour each day. The result showed their listening and communication abilities were significantly improved after training. They returned to duty 6 months later. It's important for postimplant patients to persist in listening and communication training.
F-2-02-01
INFANT NEUROLOGIC INTERNATIONAL BATTERY (INFANIB) AS A PREDICTOR OF NEUROMOTOR OUTCOME IN RISK INFANTS
In-Young Sung. Woog Kang
(University of Ulsan, College of Medicine/Asan Medical Center, Seoul, Korea)
Purpose: Infant neurologic international battery (Infanib) is one of the neurodevelopmental assessment tools. But Infanib has not been well studied for the predictability of neuromotor outcome. So we have studied correlation between Infanib results and neuromotor outcomes in risk infants.
Method: Participants consisted of 70 risk infants. The responses of the examinations were scored and then graded as normal, transient or abnormal. Through the follow-up neurodevelopmental assessment children were classified as having a normal, minor neuromotor dysfunction and definite neurologic abnormalities.
Result: All the infants of the abnormal results group (29 cases) on the initial Infanib grew into either cerebral palsy (26 cases) or minor neuromotor dysfunction (3 cases) on the follow-up whereas all the infants of the normal results group (12 cases) appeared to be in normal development. However, the transient results group (29 cases) showed variable outcomes, which were 9 cerebral palsy, 6 minor neuromotor dysfunctions, and 11 normal development.
Conclusion: This study suggests that Infanib can be a useful tool in screening the neonates and infants with subtle developmental impairments.
